Open AccessCancer Therapy: CD44v6‐Peptide Functionalized Nanoparticles Selectively Bind to Metastatic Cancer Cells (Adv. Sci. 1/2017)
Author(s) -
Li Linxian,
Schmitt Mark,
MatzkeOgi Alexandra,
Wadhwani Parvesh,
OrianRousseau Veronique,
Levkin Pavel A.
Publication year - 2017
Publication title -
advanced science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.388
H-Index - 100
ISSN - 2198-3844
DOI - 10.1002/advs.201770001
Subject(s) - cancer , peptide , nanoparticle , cancer research , cancer therapy , cancer cell , nanotechnology , chemistry , medicine , materials science , biochemistry
In article 1600202, CD44v6 peptide functionalized nanoparticles are fabricated in a facile and controllable way to selectively bind to tumor cells with highly efficient anticancer and antimetastatic properties by Veronique Orian‐Rousseau, Pavel A. Levkin, and co‐workers. The modular synthesis and facile preparation makes this system highly potent for developing novel multifunctional nanocarriers for therapeutic and/or diagnostic anticancer applications.